These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15492001)

  • 1. Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.
    Jiang H; Jiang Q; Feng J
    J Biol Chem; 2004 Dec; 279(52):54380-6. PubMed ID: 15492001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity.
    Moszczynska A; Saleh J; Zhang H; Vukusic B; Lee FJ; Liu F
    J Mol Neurosci; 2007; 32(3):217-27. PubMed ID: 17873367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.
    Wersinger C; Prou D; Vernier P; Sidhu A
    FASEB J; 2003 Nov; 17(14):2151-3. PubMed ID: 12958153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
    Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
    J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and regulation of the human dopamine transporter in a neuronal cell line.
    Zhang L; Elmer LW; Little KY
    Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
    Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B
    Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter.
    Li LB; Chen N; Ramamoorthy S; Chi L; Cui XN; Wang LC; Reith ME
    J Biol Chem; 2004 May; 279(20):21012-20. PubMed ID: 15024013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter.
    Torres GE; Carneiro A; Seamans K; Fiorentini C; Sweeney A; Yao WD; Caron MG
    J Biol Chem; 2003 Jan; 278(4):2731-9. PubMed ID: 12429746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains.
    Doss-Pepe EW; Chen L; Madura K
    J Biol Chem; 2005 Apr; 280(17):16619-24. PubMed ID: 15718234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkin suppresses the expression of monoamine oxidases.
    Jiang H; Jiang Q; Liu W; Feng J
    J Biol Chem; 2006 Mar; 281(13):8591-9. PubMed ID: 16455660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol potentiates dopamine uptake and increases cell surface distribution of dopamine transporters expressed in SK-N-SH and HEK-293 cells.
    Riherd DN; Galindo DG; Krause LR; Mayfield RD
    Alcohol; 2008 Sep; 42(6):499-508. PubMed ID: 18579334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
    Storch A; Ludolph AC; Schwarz J
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1267-86. PubMed ID: 15480838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
    Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
    Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
    Chen R; Han DD; Gu HH
    J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.
    Carneiro AM; Ingram SL; Beaulieu JM; Sweeney A; Amara SG; Thomas SM; Caron MG; Torres GE
    J Neurosci; 2002 Aug; 22(16):7045-54. PubMed ID: 12177201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.